作者: Elin Kimland , Ulf Bergman , Synnöve Lindemalm , Ylva Böttiger
DOI: 10.1007/S00431-006-0385-8
关键词:
摘要: The aim of this work was to analyse the characteristics Questions and Answers (Q&As) at a drug information centre (DIC) regarding related problems off-label treatment in children. All questions concerning children 15 years or younger DIC Stockholm, Sweden during 1995-2004 were analysed with respect main problem, drug/s group/s, whether drugs licensed not, pediatric labelling age sex patient. Q&As classified as not they included evaluated literature information, adding drugs. We identified 249 treatment. Each question addressed an average 1.5 More than two-thirds concerned adverse reactions choice dosing. Every second off-label, psychotropic being most common. In half all Q&As, documentation on efficacy safety outside Swedish catalogue medical products found. Most newborns infants. However, proportion among highest adolescence well It thus found that is common DIC. This service can provide additional based contributing safer use There still, however, substantial need for clinical